Health Topic

Public Health

Roche's response to COVID-19

Since the worldwide recognition of the novel coronavirus pandemic risk in January, we have been focused on the public health lab response to the outbreak of COVID-19. Despite the presence of industry supply challenges, Roche continues to demonstrate our commitment to providing testing platforms and required supplies to sustain and grow the testing capabilities of your lab.

COVID-19 Updates   |   Roche COVID-19 Blog


Sample Extraction and Sequencing

Solutions for RNA extraction, sequencing and LDTs

COVID-19 Research and SARS-CoV-2 Surveillance

MagNA Pure 96 System

MagNA Pure 24 System

cobas® omni channel


RT-PCR Tests

High throughput, moderate complexity testing on the cobas 6800 platform for COVID-19 and infectious diseases 

cobas® SARS-CoV-2 Test

cobas® CT/NG

cobas® ️TV/MG

cobas® HIV-1/HIV-2 Qualitative Test

cobas® HIV-1 Test

cobas® HBV Test

cobas® HCV Test

cobas® 6800 & 8800 Systems


Immunochemistry Tests

COVID-19 serology, HIV, Hepatitis, Syphilis, and ToRCH testing all on one immunoassay platform

Elecsys® Anti-SARS-CoV-2 Test

Elecsys® HIV Duo

ToRCH Panel


Point of Care & Population Health

Decentralized testing and results management platforms

cobas® SARS-CoV-2 & Influenza A/B Assay

cobas® Liat® PCR System

Found 0 results in